Sponsored by Zoetis
NSAIDs have long been the cornerstone of pharmaceutical pain relief for dogs with OA. But with the arrival of an OA monoclonal antibody therapy, is it time to rethink our approach? In this episode of Clinician’s Brief Partner Podcast, Dr. Beth invites renowned orthopedic expert Dr. John Innes to discuss how he approaches OA management, drawing from >4 years of experience with bedinvetmab in the United Kingdom. They also dive into a head-to-head study comparing bedinvetmab with an NSAID and explore what the findings mean for today’s treatment strategies.
Contact us:
Podcast@instinct.vet
Where to find us:
Twitter:
Instagram:
The Team:
Beth Molleson, DVM - Host
Sarah Pate - Producer & Project Manager, Brief Studio
Taylor Argo - Podcast Production & Sound Editing
